# FDA Inspection 1174496 - Robert Hayashi M.D - July 08, 2022

Source: https://www.globalkeysolutions.net/records/fda_inspections/robert-hayashi-md/f9c98644-05c8-43bf-8742-19edc477c3e7/
Source feed: FDA_Inspections

> FDA Inspection 1174496 for Robert Hayashi M.D on July 08, 2022. Classification: Official Action Indicated (OAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1174496
- Company Name: Robert Hayashi M.D
- Inspection Date: 2022-07-08
- Classification: Official Action Indicated (OAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1281155 - 2025-08-29](https://www.globalkeysolutions.net/api/records/fda_inspections/robert-hayashi-md/2cf439ef-5563-4a2b-bd43-d45996600143/)
- [FDA Inspection 1281155 - 2025-08-29](https://www.globalkeysolutions.net/api/records/fda_inspections/robert-hayashi-md/ca6541e8-406b-45c4-ab80-cf1112b49725/)

Company: https://www.globalkeysolutions.net/companies/robert-hayashi-md/d086cfb8-b6fd-4ae5-be14-e381f7f84a4b

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c